Physician profile
Caroline Perkowski
NPI 1962852277
$338.03
in general payments reported to CMS, 2019-2025
12 companies · $85.38 in 2025
The $85.38 reported for 2025 was less than what a typical Pediatrics provider received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $95.34 · 2023: $99.57 · 2024: $57.74 · 2025: $85.38.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $243.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $242.69 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alk-Abello, INC | $48.38 | 2024-2025 | Grastek, Ragwitek, Odactra |
| Sanofi Pasteur INC. | $47.46 | 2023 | |
| Corium, LLC | $37.56 | 2022-2025 | Azstarys |
| Kaleo, INC. | $33.99 | 2022 | |
| Merck Sharp & Dohme LLC | $33.54 | 2023 | Gardasil 9, Vaxelis, Rotateq |
| Glaxosmithkline, LLC. | $28.41 | 2022 | |
| Cranial Technologies, INC | $27.41 | 2024 | Doc Band |
| Sanofi-Aventis U.S. LLC | $18.57 | 2023 | |
| Alexion Pharmaceuticals, INC. | $17.24 | 2025 | Strensiq |
| Pfizer INC. | $16.50 | 2022 | |
| Supernus Pharmaceuticals, INC. | $14.50 | 2025 | Qelbree |
| Verrica Pharmaceuticals INC. | $14.47 | 2025 | Ycanth |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Caroline Perkowski listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.